Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-26

Clinical Trial Update: Role of CBD in Improving Alexithymia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the University of California, San Diego investigating cannabidiol (CBD) for improving alexithymia in individuals with HIV …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: University of California, San Diego | Conditions: Alexithymia, HIV | Phase 2 | Status: TERMINATED